29 related articles for article (PubMed ID: 8166227)
1. Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation.
Wang HL; Auerbach A; Bren N; Ohno K; Engel AG; Sine SM
J Gen Physiol; 1997 Jun; 109(6):757-66. PubMed ID: 9222901
[TBL] [Abstract][Full Text] [Related]
2. Allosteric inhibition of muscle-type nicotinic acetylcholine receptors by a neuromuscular blocking agent pancuronium.
Sakata S; Ono F
PLoS One; 2023; 18(10):e0292262. PubMed ID: 37824562
[TBL] [Abstract][Full Text] [Related]
3. High Throughput Random Mutagenesis and Single Molecule Real Time Sequencing of the Muscle Nicotinic Acetylcholine Receptor.
Groot-Kormelink PJ; Ferrand S; Kelley N; Bill A; Freuler F; Imbert PE; Marelli A; Gerwin N; Sivilotti LG; Miraglia L; Orth AP; Oakeley EJ; Schopfer U; Siehler S
PLoS One; 2016; 11(9):e0163129. PubMed ID: 27649498
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a human neuronal nAChR extracellular domain in pentameric assembly: Ligand-bound α2 homopentamer.
Kouvatsos N; Giastas P; Chroni-Tzartou D; Poulopoulou C; Tzartos SJ
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9635-40. PubMed ID: 27493220
[TBL] [Abstract][Full Text] [Related]
5. A structural and mutagenic blueprint for molecular recognition of strychnine and d-tubocurarine by different cys-loop receptors.
Brams M; Pandya A; Kuzmin D; van Elk R; Krijnen L; Yakel JL; Tsetlin V; Smit AB; Ulens C
PLoS Biol; 2011 Mar; 9(3):e1001034. PubMed ID: 21468359
[TBL] [Abstract][Full Text] [Related]
6. Glycine hinges with opposing actions at the acetylcholine receptor-channel transmitter binding site.
Purohit P; Auerbach A
Mol Pharmacol; 2011 Mar; 79(3):351-9. PubMed ID: 21115636
[TBL] [Abstract][Full Text] [Related]
7. Energetics of gating at the apo-acetylcholine receptor transmitter binding site.
Purohit P; Auerbach A
J Gen Physiol; 2010 Apr; 135(4):321-31. PubMed ID: 20351060
[TBL] [Abstract][Full Text] [Related]
8. Allosteric activation mechanism of the cys-loop receptors.
Chang YC; Wu W; Zhang JL; Huang Y
Acta Pharmacol Sin; 2009 Jun; 30(6):663-72. PubMed ID: 19444220
[TBL] [Abstract][Full Text] [Related]
9. The acetylcholinesterase inhibitor BW284c51 is a potent blocker of Torpedo nicotinic AchRs incorporated into the Xenopus oocyte membrane.
Olivera-Bravo S; Ivorra I; Morales A
Br J Pharmacol; 2005 Jan; 144(1):88-97. PubMed ID: 15644872
[TBL] [Abstract][Full Text] [Related]
10. Nicotinic acetylcholine receptors in health and disease.
Lindstrom J
Mol Neurobiol; 1997 Oct; 15(2):193-222. PubMed ID: 9396010
[TBL] [Abstract][Full Text] [Related]
11. A model of the nicotinic receptor extracellular domain based on sequence identity and residue location.
Tsigelny I; Sugiyama N; Sine SM; Taylor P
Biophys J; 1997 Jul; 73(1):52-66. PubMed ID: 9199771
[TBL] [Abstract][Full Text] [Related]
12. d-Tubocurarine binding sites are located at alpha-gamma and alpha-delta subunit interfaces of the nicotinic acetylcholine receptor.
Pedersen SE; Cohen JB
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2785-9. PubMed ID: 2320589
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of ligand-induced activation of the Torpedo acetylcholine receptor.
O'Leary ME; White MM
J Biol Chem; 1992 Apr; 267(12):8360-5. PubMed ID: 1569088
[TBL] [Abstract][Full Text] [Related]
14. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
Arias HR
Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
[TBL] [Abstract][Full Text] [Related]
15. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
Arias HR
Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
[TBL] [Abstract][Full Text] [Related]
16. Characterization of d-tubocurarine binding site of Torpedo acetylcholine receptor.
O'Leary ME; Filatov GN; White MM
Am J Physiol; 1994 Mar; 266(3 Pt 1):C648-53. PubMed ID: 8166227
[TBL] [Abstract][Full Text] [Related]
17. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants.
Chiara DC; Xie Y; Cohen JB
Biochemistry; 1999 May; 38(20):6689-98. PubMed ID: 10350488
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
